MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1339.75%
Quick Ratio
1339.75%
Cash Ratio
1229.38%
Debt to Asset Ratio
8.52%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Other assets
    • Fixed assets, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
43,181,002
50,724,643
46,822,786
28,129,866
Prepaids and other current assets
3,876,735
2,538,036
3,116,232
3,894,944
Total current assets
47,057,737
53,262,679
49,939,018
32,024,810
Fixed assets, net
5,614
8,420
11,227
18,068
Other assets
244,727
-
-
-
Total assets
47,308,078
53,271,099
49,950,245
32,042,878
Accounts payable
1,085,519
948,192
1,061,122
1,111,702
Accrued expenses
1,193,460
1,355,714
3,612,913
1,638,706
Deferred collaboration revenue
1,233,452
1,242,635
1,197,856
916,712
Total current liabilities
3,512,431
3,546,541
5,871,891
3,667,120
Deferred collaboration revenue
519,636
754,198
1,050,124
1,091,267
Total liabilities
4,032,067
4,300,739
6,922,015
4,758,387
Common stock, 0.0001 par value 200,000,000 shares authorized 23,457,849 and 20,934,456 shares issued and outstanding as of june 30, 2026 or december 31, 2025, respectively
2,346
2,346
2,094
1,675
Additional paid-in capital
119,082,192
118,138,281
104,989,413
83,537,551
Accumulated deficit
-75,808,527
-69,170,267
-61,963,277
-56,254,735
Total stockholders' equity
43,276,011
48,970,360
43,028,230
27,284,491
Total liabilities and stockholders' equity
47,308,078
53,271,099
49,950,245
32,042,878
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$43,181,002 (45.11%↑ Y/Y)Prepaids and othercurrent assets$3,876,735 (5.62%↑ Y/Y)Total current assets$47,057,737 (40.77%↑ Y/Y)Other assets$244,727 Fixed assets, net$5,614 (-77.46%↓ Y/Y)Total assets$47,308,078 (41.42%↑ Y/Y)Total liabilities andstockholders' equity$47,308,078 (41.42%↑ Y/Y)Total stockholders'equity$43,276,011 (52.86%↑ Y/Y)Total liabilities$4,032,067 (-21.59%↓ Y/Y)Accumulated deficit-$75,808,527 (-40.03%↓ Y/Y)Additional paid-in capital$119,082,192 (44.43%↑ Y/Y)Total currentliabilities$3,512,431 (-21.97%↓ Y/Y)Deferred collaborationrevenue$519,636 (-18.95%↓ Y/Y)Common stock, 0.0001par value...$2,346 (40.23%↑ Y/Y)Deferred collaborationrevenue$1,233,452 (68.72%↑ Y/Y)Accrued expenses$1,193,460 (-57.96%↓ Y/Y)Accounts payable$1,085,519 (16.55%↑ Y/Y)

Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA)